ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 64 filers reported holding ADAMAS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $15,000 | +1400.0% | 3,236 | +627.2% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 445 | +46.4% | 0.00% | – |
| Q3 2020 | $1,000 | -99.1% | 304 | -99.2% | 0.00% | – |
| Q1 2020 | $108,000 | -32.1% | 37,509 | -11.1% | 0.00% | – |
| Q4 2019 | $159,000 | +123.9% | 42,188 | +201.5% | 0.00% | – |
| Q3 2019 | $71,000 | +54.3% | 13,991 | +84.7% | 0.00% | – |
| Q2 2019 | $46,000 | -31.3% | 7,574 | -20.4% | 0.00% | – |
| Q1 2019 | $67,000 | +346.7% | 9,517 | +413.9% | 0.00% | – |
| Q4 2018 | $15,000 | -95.9% | 1,852 | -90.0% | 0.00% | -100.0% |
| Q3 2018 | $370,000 | +168.1% | 18,501 | +244.9% | 0.00% | 0.0% |
| Q2 2018 | $138,000 | +40.8% | 5,364 | +29.8% | 0.00% | -75.0% |
| Q1 2018 | $98,000 | -87.1% | 4,134 | -88.5% | 0.00% | -87.1% |
| Q3 2017 | $762,000 | +76.4% | 36,024 | +135.7% | 0.03% | -8.8% |
| Q4 2015 | $432,000 | – | 15,281 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 751,012 | $3,841,000 | 3.73% |
| Healthcare Value Capital, LLC | 200,000 | $1,023,000 | 1.85% |
| DELTEC ASSET MANAGEMENT LLC | 574,886 | $2,941,000 | 0.74% |
| Kerrisdale Advisers, LLC | 229,347 | $1,173,000 | 0.74% |
| Mosaic Family Wealth, LLC | 91,314 | $609,000 | 0.25% |
| Worth Venture Partners, LLC | 77,384 | $396,000 | 0.23% |
| ARMISTICE CAPITAL, LLC | 536,000 | $2,742,000 | 0.18% |
| EMERALD ADVISERS, LLC | 639,094 | $3,269,000 | 0.15% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 609,019 | $3,115,000 | 0.14% |
| DUDLEY & SHANLEY, INC. | 67,400 | $345,000 | 0.08% |